Interventional Radiology in the Treatment of Pancreatic Adenocarcinoma: Present and Future Perspectives
- PMID: 36983990
- PMCID: PMC10059735
- DOI: 10.3390/life13030835
Interventional Radiology in the Treatment of Pancreatic Adenocarcinoma: Present and Future Perspectives
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease; patients' long-term survival is strictly linked to the surgical resection of the tumor but only a minority of patients (2-3%) have a resectable disease at diagnosis. In patients with surgically unresectable disease, interventional radiology is taking on an increasing role in treatment with the application of loco-regional percutaneous therapies. The primary purposes of this narrative review are to analyze the safety and efficacy of ablative techniques in the management of borderline resectable and locally advanced diseases and to underline the role of the interventional radiologist in the management of patients with distant metastases. The secondary purpose is to focus on the synergy between immunotherapy and ablative therapies.
Keywords: immunotherapy; irreversible electroporation; liver metastases chemoembolization; pancreatic adenocarcinoma; thermal ablation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Tempero M.A., Malafa M.P., Al-Hawary M., Behrman S.W., Benson A.B., III, Cardin D.B., Chiorean E.G., Chung V., Czito B., Chiaro M.B., et al. Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Cancer Netw. 2021;19:439–457. doi: 10.6004/jnccn.2021.0017. - DOI - PubMed
-
- Ducreux M., Cuhna A.S., Caramella C., Hollebecque A., Burtin P., Goéré D., Seufferlein T., Haustermans K., Van Laethem J.L., Conroy T., et al. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2015;26((Suppl. S5)):v56–v68. doi: 10.1093/annonc/mdv295. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources